Literature DB >> 19626705

Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules.

Jacob L Jordan1, Joseph W Arndt, Karl Hanf, Guohui Li, Janine Hall, Stephen Demarest, Flora Huang, Xiufeng Wu, Brian Miller, Scott Glaser, Erik J Fernandez, Deping Wang, Alexey Lugovskoy.   

Abstract

Bispecific immunoglobulin-like antibodies capable of engaging multiple antigens represent a promising new class of therapeutic agents. Engineering of these molecules requires optimization of the molecular properties of one of the domain components. Here, we present a detailed crystallographic and computational characterization of the stabilization patterns in the lymphotoxin-beta receptor (LTbetaR) binding Fv domain of an anti-LTbetaR/anti-TNF-related apoptosis inducing ligand receptor-2 (TRAIL-R2) bispecific immunoglobulin-like antibody. We further describe a new hierarchical structure-guided approach toward engineering of antibody-like molecules to enhance their thermal and chemical stability. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626705     DOI: 10.1002/prot.22502

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  16 in total

1.  Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity.

Authors:  Jianying Dong; Arlene Sereno; William B Snyder; Brian R Miller; Susan Tamraz; Adam Doern; Michael Favis; Xiufeng Wu; Hon Tran; Emma Langley; Ingrid Joseph; Antonio Boccia; Rebecca Kelly; Kathleen Wortham; Qin Wang; Lisa Berquist; Flora Huang; Sharon X Gao; Ying Zhang; Alexey Lugovskoy; Shelly Martin; Heather Gouvis; Steven Berkowitz; Gisela Chiang; Mitchell Reff; Scott M Glaser; Kandasamy Hariharan; Stephen J Demarest
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 2.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

3.  Mutations in Antibody Fragments Modulate Allosteric Response Via Hydrogen-Bond Network Fluctuations.

Authors:  Amit Srivastava; Malgorzata B Tracka; Shahid Uddin; Jose Casas-Finet; Dennis R Livesay; Donald J Jacobs
Journal:  Biophys J       Date:  2016-05-10       Impact factor: 4.033

4.  A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv).

Authors:  Chao Tu; Virginie Terraube; Amy Sze Pui Tam; Wayne Stochaj; Brian J Fennell; Laura Lin; Mark Stahl; Edward R LaVallie; Will Somers; William J J Finlay; Lydia Mosyak; Joel Bard; Orla Cunningham
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

5.  Modulating non-native aggregation and electrostatic protein-protein interactions with computationally designed single-point mutations.

Authors:  C J O'Brien; M A Blanco; J A Costanzo; M Enterline; E J Fernandez; A S Robinson; C J Roberts
Journal:  Protein Eng Des Sel       Date:  2016-05-09       Impact factor: 1.650

6.  Rational engineering of antibody therapeutics targeting multiple oncogene pathways.

Authors:  Jonathan Fitzgerald; Alexey Lugovskoy
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

7.  Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.

Authors:  K J Froning; A Leaver-Fay; X Wu; S Phan; L Gao; F Huang; A Pustilnik; M Bacica; K Houlihan; Q Chai; J R Fitchett; J Hendle; B Kuhlman; S J Demarest
Journal:  Protein Sci       Date:  2017-07-31       Impact factor: 6.725

8.  Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.

Authors:  Kathy Zhang; Melissa L Geddie; Neeraj Kohli; Tad Kornaga; Dmitri B Kirpotin; Yang Jiao; Rachel Rennard; Daryl C Drummond; Ulrik B Nielsen; Lihui Xu; Alexey A Lugovskoy
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Computer-based Engineering of Thermostabilized Antibody Fragments.

Authors:  Jiwon Lee; Bryan S Der; Christos S Karamitros; Wenzong Li; Nicholas M Marshall; Oana I Lungu; Aleksandr E Miklos; Jianqing Xu; Tae Hyun Kang; Chang-Han Lee; Bing Tan; Randall A Hughes; Sang Taek Jung; Gregory C Ippolito; Jeffrey J Gray; Yan Zhang; Brian Kuhlman; George Georgiou; Andrew D Ellington
Journal:  AIChE J       Date:  2019-11-19       Impact factor: 3.993

10.  A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation.

Authors:  Yang Shen; Lin Zeng; Ruslan Novosyadlyy; Amelie Forest; Aiping Zhu; Andrew Korytko; Haifan Zhang; Scott W Eastman; Michael Topper; Sagit Hindi; Nicole Covino; Kris Persaud; Yun Kang; Douglas Burtrum; David Surguladze; Marie Prewett; Sudhakar Chintharlapalli; Victor J Wroblewski; Juqun Shen; Paul Balderes; Zhenping Zhu; Marshall Snavely; Dale L Ludwig
Journal:  MAbs       Date:  2015       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.